Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer

نویسندگان

  • Giovanni Ciriello
  • Michael L. Gatza
  • Andrew H. Beck
  • Matthew D. Wilkerson
  • Suhn K. Rhie
  • Alessandro Pastore
  • Hailei Zhang
  • Michael McLellan
  • Christina Yau
  • Cyriac Kandoth
  • Reanne Bowlby
  • Hui Shen
  • Sikander Hayat
  • Robert Fieldhouse
  • Susan C. Lester
  • Gary M.K. Tse
  • Rachel E. Factor
  • Laura C. Collins
  • Kimberly H. Allison
  • Yunn-Yi Chen
  • Kristin Jensen
  • Nicole B. Johnson
  • Steffi Oesterreich
  • Gordon B. Mills
  • Andrew D. Cherniack
  • Gordon Robertson
  • Christopher Benz
  • Chris Sander
  • Peter W. Laird
  • Katherine A. Hoadley
  • Tari A. King
  • Charles M. Perou
چکیده

Invasive lobular carcinoma (ILC) is the second most prevalent histologic subtype of invasive breast cancer. Here, we comprehensively profiled 817 breast tumors, including 127 ILC, 490 ductal (IDC), and 88 mixed IDC/ILC. Besides E-cadherin loss, the best known ILC genetic hallmark, we identified mutations targeting PTEN, TBX3, and FOXA1 as ILC enriched features. PTEN loss associated with increased AKT phosphorylation, which was highest in ILC among all breast cancer subtypes. Spatially clustered FOXA1 mutations correlated with increased FOXA1 expression and activity. Conversely, GATA3 mutations and high expression characterized luminal A IDC, suggesting differential modulation of ER activity in ILC and IDC. Proliferation and immune-related signatures determined three ILC transcriptional subtypes associated with survival differences. Mixed IDC/ILC cases were molecularly classified as ILC-like and IDC-like revealing no true hybrid features. This multidimensional molecular atlas sheds new light on the genetic bases of ILC and provides potential clinical options.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Invasive lobular carcinoma of the male breast – a systematic review with an illustrative case study

Male breast cancer is rare, comprising only 1% of all mammary cancers; invasive ductal carcinoma is by far the commonest subtype in both men and women. Though lobular breast cancer is the second most common subtype seen in women, such cancers are extremely uncommon in men, and this is likely related to the lack of lobular development in the male breast. Thus, due to the rarity of this subtype a...

متن کامل

بررسی فراوانی بروز مارکرهای E-Cadherin , Dysadherinدر کارسینوم های پستان

Background and purpose: Breast carcinoma is the most common malignant tumor and the leading cause of death due to cancer among women. Previous studies have shown that increased expression of dysadherin promotes cancer metastasis and reduced expression of E-cadherin was also associated with progression of epithelial tumors. The aim of this study was concurrent assessment of E- cadherin and dysad...

متن کامل

INVASIVE LOBULAR BREAST CARCINOMA: Pathology and genetics reflected by MRI

SOURCES 1. Varga Z, Mallon E.Histology and Immunophenotype of Invasive Lobular Breast Cancer. Daily Practice and Pitfalls. Breast Dis. 2009 Oct 21;30:15-19. 2. Weigelt B, Geyer FC, et al. The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and gradeand molecular subtype-matched invasive ductal carcinomas of no s...

متن کامل

A Rare Case of Invasive Lobular Breast Cancer in a Male

Male breast cancer is rare, comprising 1% of all breast cancers and 1% of all cancers in men. Unlike in women, in men invasive lobular breast cancer (ILC) is very uncommon, making up 1% of all male breast cancers and 0.01% of all cancers in men. In the past, the low incidence of lobular breast cancer in men was thought to be due to a lack of lobular tissue in the male breast. However, the class...

متن کامل

Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer

Invasive lobular carcinoma (ILC) is the second most frequently occurring histological breast cancer subtype after invasive ductal carcinoma (IDC), accounting for around 10% of all breast cancers. The molecular processes that drive the development of ILC are still largely unknown. We have performed a comprehensive genomic, transcriptomic and proteomic analysis of a large ILC patient cohort and p...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Cell

دوره 163  شماره 

صفحات  -

تاریخ انتشار 2015